Biodesix® Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy
Biodesix presents data at the World Lung Conference showing the ability to stratify lung cancer patients treated with immunotherapy
254 Results
Biodesix presents data at the World Lung Conference showing the ability to stratify lung cancer patients treated with immunotherapy
Horizon Blue Cross Blue Shield (BCBS) of New Jersey has determined that the VeriStrat® proteomic test is now considered a medically necessary benefit for members with advanced NSCLC.